Allogeneic stem cell transplantation with reduced-intensity, fludarabine-based conditioning in relapsed and refractory Hodgkin's disease: Low transplant-related mortality and impact of intensity of conditioning regimen on survival.

被引：0
|
作者：
Anderlini, P [1 ]
Saliba, R [1 ]
Donato, M [1 ]
Giralt, S [1 ]
Andersson, B [1 ]
Ueno, NT [1 ]
Khouri, IF [1 ]
de Lima, M [1 ]
Ippoliti, C [1 ]
Champlin, RE [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.2135.2135
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2135
引用
收藏
页码：587A / 587A
页数：1
相关论文
共 50 条
  • [31] The impact of donor lymphocyte infusions following reduced-intensity conditioning allogeneic stem cell transplantation for Hodgkin's disease
    Robinson, S. P.
    Canals, C.
    Taghipour, G.
    Martino, R.
    Michallet, M.
    Carella, A. M.
    Liakopoulou, E.
    Sureda, A.
    Schmitz, N.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S24 - S24
  • [32] Thiotepa and fludarabine as reduced-intensity conditioning regimen followed by allogeneic peripheral stem cell transplantation for hematologic malignancies
    Alessandrino, EP
    Bernasconi, P
    Colombo, AA
    Caldera, D
    Malcovati, L
    Varettoni, M
    Rumi, E
    Baraté, C
    Ardizzone, F
    Lazzarino, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S155 - S155
  • [33] Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies
    E P Alessandrino
    P Bernasconi
    A A Colombo
    D Caldera
    L Malcovati
    D Troletti
    L Vanelli
    M Varettoni
    F Montanari
    M Lazzarino
    Bone Marrow Transplantation, 2004, 34 : 1039 - 1045
  • [34] Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies
    Alessandrino, EP
    Bernasconi, P
    Colombo, AA
    Caldera, D
    Malcovati, L
    Troletti, D
    Vanelli, L
    Varettoni, M
    Montanari, F
    Lazzarino, M
    BONE MARROW TRANSPLANTATION, 2004, 34 (12) : 1039 - 1045
  • [35] Allogeneic hematopoietic cell transplant with fludarabine-based reduced-intensity conditioning as treatment for advanced chronic lymphocytic leukemia
    Delioukina, Maria L.
    Palmer, Joycelynne M.
    Thomas, Sandra H.
    Krishnan, Amrita
    Stiller, Tracey
    Forman, Stephen J.
    LEUKEMIA & LYMPHOMA, 2011, 52 (04) : 719 - 723
  • [36] Impact of Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation on Women's Fertility
    Assouline, Emmanuelle
    Crocchiolo, Roberto
    Prebet, Thomas
    Broussais, Florence
    Coso, Diane
    Gamerre, Marc
    Vey, Norbert
    Blaise, Didier
    Courbiere, Blandine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (06): : 704 - 710
  • [37] Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience
    Le Gouill, S.
    Kroeger, N.
    Dhedin, N.
    Nagler, A.
    Bouabdallah, K.
    Yakoub-Agha, I.
    Kanouni, T.
    Bulabois, C. E.
    Tournilhac, O.
    Buzyn, A.
    Rio, B.
    Moles, M. P.
    Shimoni, A.
    Bacher, U.
    Ocheni, S.
    Milpied, N.
    Harousseau, J. L.
    Moreau, P.
    Leux, C.
    Mohty, M.
    ANNALS OF ONCOLOGY, 2012, 23 (10) : 2695 - 2703
  • [38] Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML
    Christopoulos, P.
    Schmoor, C.
    Waterhouse, M.
    Marks, R.
    Waesch, R.
    Bertz, H.
    Finke, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 (07) : 901 - 907
  • [39] Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens
    Bertz, H
    Illerhaus, G
    Veelken, H
    Finke, J
    ANNALS OF ONCOLOGY, 2002, 13 (01) : 135 - 139
  • [40] Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML
    P Christopoulos
    C Schmoor
    M Waterhouse
    R Marks
    R Wäsch
    H Bertz
    J Finke
    Bone Marrow Transplantation, 2013, 48 : 901 - 907
12345